United States Biotechnology & Medical Research

Immunovant Inc (IMVT)

Track

Over the past 90 days, Immunovant Inc. insiders have engaged in 38 transactions, all of which were sales, totaling approximately $23.3 million in value. Key executives, including the CEO, CFO, and CTO, have offloaded shares. This selling activity follows a period where the stock price rose 37.7%, currently trading near its 52-week high.
Ticker: IMVT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Immunovant Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 24 Jul 2026
Value US$4,447,569.19 | Price 133.18 | Shares 96,016 (-3.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-24 2026-07-24 PlS Planned sale
3.4
Pande Atul
Non-Executive Director
96,016 -3.2%
133.18
US$4,447,569 		96,016 -3.2% 133.18 US$4,447,569
2026-07-24 2026-07-23 S Sale
Girao Tiago

Chief Financial Officer

Officer
34,560 +30.2%
301.90
US$1,585,829 		34,560 +30.2% 301.90 US$1,585,829
2026-07-24 2026-07-23 S Sale
2.4
Stout Jay S

Chief Technology Officer

Officer
51,776 -21.6%
13.33
US$169,247 		51,776 -21.6% 13.33 US$169,247
2026-07-10 2026-07-08 S Sale
1.8
Gloria Melanie

Chief Operating Officer

Officer
106 -0.0%
39.99
US$4,239 		106 -0.0% 39.99 US$4,239
2026-07-10 2026-07-08 S Sale
1.8
Gloria Melanie

Chief Operating Officer

Officer
1,930 -0.9%
39.53
US$76,293 		1,930 -0.9% 39.53 US$76,293
2026-07-10 2026-07-08 S Sale
1.8
Van Tuyl Christopher

Chief Legal Officer

Officer
63 -0.0%
39.99
US$2,519 		63 -0.0% 39.99 US$2,519
2026-07-10 2026-07-08 S Sale
1.8
Van Tuyl Christopher

Chief Legal Officer

Officer
1,143 -0.6%
39.53
US$45,183 		1,143 -0.6% 39.53 US$45,183
2026-07-10 2026-07-08 S Sale
2.4
Stout Jay S

Chief Technology Officer

Officer
77 -0.0%
39.99
US$3,079 		77 -0.0% 39.99 US$3,079
2026-07-10 2026-07-08 S Sale
2.4
Stout Jay S

Chief Technology Officer

Officer
1,399 -0.7%
39.53
US$55,302 		1,399 -0.7% 39.53 US$55,302
2026-07-10 2026-07-08 S Sale
2.4
Stout Jay S

Chief Technology Officer

Officer
105 -0.1%
39.99
US$4,199 		105 -0.1% 39.99 US$4,199
2026-07-10 2026-07-08 S Sale
2.4
Stout Jay S

Chief Technology Officer

Officer
1,906 -0.9%
39.53
US$75,344 		1,906 -0.9% 39.53 US$75,344
2026-07-06 2026-07-02 S Sale
2.2
Venker Eric

Chief Executive Officer

Executive Director
3,092 -1.2%
38.48
US$118,980 		3,092 -1.2% 38.48 US$118,980
2026-06-26 2026-06-26 S Sale
1.8
Gloria Melanie

Chief Operating Officer

Officer
2,966 -1.3%
38.95
US$115,526 		2,966 -1.3% 38.95 US$115,526
2026-06-26 2026-06-26 S Sale
1.8
Gloria Melanie

Chief Operating Officer

Officer
14,748 -6.1%
38.18
US$563,079 		14,748 -6.1% 38.18 US$563,079
2026-06-26 2026-06-26 S Sale
2.4
Stout Jay S

Chief Technology Officer

Officer
6,723 -3.1%
38.94
US$261,794 		6,723 -3.1% 38.94 US$261,794
2026-06-26 2026-06-26 S Sale
2.4
Stout Jay S

Chief Technology Officer

Officer
33,277 -13.2%
38.18
US$1,270,516 		33,277 -13.2% 38.18 US$1,270,516
2026-06-26 2026-06-26 S Sale
1.8
Van Tuyl Christopher

Chief Legal Officer

Officer
2,842 -1.5%
38.96
US$110,724 		2,842 -1.5% 38.96 US$110,724
2026-06-26 2026-06-26 S Sale
1.8
Van Tuyl Christopher

Chief Legal Officer

Officer
14,982 -7.6%
38.19
US$572,163 		14,982 -7.6% 38.19 US$572,163
2026-06-26 2026-06-26 S Sale
Girao Tiago

Chief Financial Officer

Officer
10,000 -3.9%
38.46
US$384,600 		10,000 -3.9% 38.46 US$384,600
2026-06-26 2026-06-26 PlS Planned sale
3.4
Pande Atul
Non-Executive Director
1,500 -1.3%
38.01
US$57,015 		1,500 -1.3% 38.01 US$57,015
2026-06-26 2026-06-26 PrS Proposed sale
2.4
JAY S STOUT

Officer

Officer
40,000
38.30
US$1,532,196 		40,000 38.30 US$1,532,196
2026-06-26 2026-06-26 PrS Proposed sale
1.8
CHRIS ADAIR VAN TUYL

Officer; Director

Executive Director
17,824
38.31
US$682,800 		17,824 38.31 US$682,800
2026-06-26 2026-06-26 PrS Proposed sale
TIAGO GIRAO

Officer

Officer
10,000
38.46
US$384,640 		10,000 38.46 US$384,640
2026-06-26 2026-06-26 PrS Proposed sale
1.8
MELANIE GLORIA

Officer

Officer
17,714
38.31
US$678,552 		17,714 38.31 US$678,552
2026-06-22 2026-06-18 S Sale
1.8
Van Tuyl Christopher

Chief Legal Officer

Officer
2,634 -1.4%
35.39
US$93,217 		2,634 -1.4% 35.39 US$93,217
2026-06-22 2026-06-18 S Sale
1.8
Van Tuyl Christopher

Chief Legal Officer

Officer
2,634 -1.4%
35.39
US$93,217 		2,634 -1.4% 35.39 US$93,217
2026-06-16 2026-06-15 PlS Planned sale
3.4
Pande Atul
Non-Executive Director
1,500 -1.3%
34.02
US$51,030 		1,500 -1.3% 34.02 US$51,030
2026-06-15 2026-06-15 PrS Proposed sale
3.4
Atul Pande

Director

Non-Executive Director
6,000
33.62
US$201,720 		6,000 33.62 US$201,720
2026-05-29 2026-05-28 S Sale
Fromkin Andrew J.
Non-Executive Director
210,468 -73.9%
33.56
US$7,063,306 		210,468 -73.9% 33.56 US$7,063,306
2026-05-29 2026-05-28 S Sale
Fromkin Andrew J.
Non-Executive Director
11,483 -3.9%
32.64
US$374,805 		11,483 -3.9% 32.64 US$374,805
2026-05-28 2026-05-28 PrS Proposed sale
ANDREW J FROMKIN

Director

Non-Executive Director
221,951
33.52
US$7,438,710 		221,951 33.52 US$7,438,710
2026-05-22 2026-05-20 S Sale
1.8
Gloria Melanie

Chief Operating Officer

Officer
1,698 -0.7%
32.95
US$55,949 		1,698 -0.7% 32.95 US$55,949
2026-05-22 2026-05-20 S Sale
1.8
Gloria Melanie

Chief Operating Officer

Officer
1,168 -0.5%
32.15
US$37,551 		1,168 -0.5% 32.15 US$37,551
2026-05-22 2026-05-20 S Sale
1.8
Gloria Melanie

Chief Operating Officer

Officer
249 -0.1%
30.41
US$7,572 		249 -0.1% 30.41 US$7,572
2026-05-20 2026-05-20 PlS Planned sale
3.4
Pande Atul
Non-Executive Director
6,000 -4.9%
32.00
US$192,000 		6,000 -4.9% 32.00 US$192,000
2026-05-20 2026-05-20 PrS Proposed sale
3.4
Atul Pande

Director

Non-Executive Director
6,000
26.29
US$157,740 		6,000 26.29 US$157,740
2026-05-01 2026-05-01 PlS Planned sale
Susman Robert Graham
Non-Executive Director
2,502 -6.4%
27.17
US$67,979 		2,502 -6.4% 27.17 US$67,979
2026-05-01 2026-05-01 PrS Proposed sale
ROBERT G SUSMAN

Director

Non-Executive Director
2,502
27.14
US$67,917 		2,502 27.14 US$67,917
2026-04-24 2026-04-23 S Sale
Girao Tiago

Chief Financial Officer

Officer
25,760 -9.4%
29.62
US$763,011 		25,760 -9.4% 29.62 US$763,011
2026-04-24 2026-04-23 S Sale
2.4
Stout Jay S

Chief Technology Officer

Officer
2,754 -1.1%
29.62
US$81,573 		2,754 -1.1% 29.62 US$81,573
2026-04-10 2026-04-08 S Sale
1.8
Van Tuyl Christopher

Chief Legal Officer

Officer
5,165 -2.7%
24.83
US$128,247 		5,165 -2.7% 24.83 US$128,247
2026-04-10 2026-04-08 S Sale
1.8
Gloria Melanie

Chief Operating Officer

Officer
8,722 -3.4%
24.83
US$216,567 		8,722 -3.4% 24.83 US$216,567
2026-04-10 2026-04-08 S Sale
1.8
Gloria Melanie

Chief Operating Officer

Officer
8,722 -3.4%
24.83
US$216,567 		8,722 -3.4% 24.83 US$216,567
2026-04-10 2026-04-08 S Sale
2.4
Stout Jay S

Chief Technology Officer

Officer
1,518 -0.6%
24.83
US$37,692 		1,518 -0.6% 24.83 US$37,692
2026-04-10 2026-04-08 S Sale
2.4
Stout Jay S

Chief Technology Officer

Officer
8,614 -3.3%
24.83
US$213,886 		8,614 -3.3% 24.83 US$213,886
2026-04-03 2026-04-02 S Sale
2.2
Venker Eric

Chief Executive Officer

Executive Director
1,409 -6.7%
24.60
US$34,661 		1,409 -6.7% 24.60 US$34,661
2026-04-03 2026-04-02 S Sale
2.2
Venker Eric

Chief Executive Officer

Executive Director
12,820 -37.9%
24.04
US$308,193 		12,820 -37.9% 24.04 US$308,193
2026-03-20 2026-03-18 S Sale
1.8
Van Tuyl Christopher

Chief Legal Officer

Officer
2,877 -1.9%
24.97
US$71,839 		2,877 -1.9% 24.97 US$71,839
2026-02-27 2026-02-25 S Sale
1.8
Gloria Melanie

Chief Operating Officer

Officer
942 -0.6%
28.90
US$27,224 		942 -0.6% 28.90 US$27,224
2026-02-27 2026-02-25 S Sale
1.8
Gloria Melanie

Chief Operating Officer

Officer
859 -0.5%
28.16
US$24,189 		859 -0.5% 28.16 US$24,189
2026-02-27 2026-02-25 S Sale
1.8
Gloria Melanie

Chief Operating Officer

Officer
1,437 -0.8%
26.98
US$38,770 		1,437 -0.8% 26.98 US$38,770
2026-02-10 2026-02-10 PrS Proposed sale
3.3
MICHAEL GEFFNER

Officer

Officer
5,800
26.77
US$155,237 		5,800 26.77 US$155,237
2026-01-23 2026-01-21 S Sale
2.4
Stout Jay S

Chief Technology Officer

Officer
1,977 -1.0%
26.03
US$51,461 		1,977 -1.0% 26.03 US$51,461
2026-01-09 2026-01-07 S Sale
2.4
Stout Jay S

Chief Technology Officer

Officer
55 -0.0%
26.92
US$1,481 		55 -0.0% 26.92 US$1,481
2026-01-09 2026-01-07 S Sale
2.4
Stout Jay S

Chief Technology Officer

Officer
1,148 -0.6%
26.51
US$30,433 		1,148 -0.6% 26.51 US$30,433
2025-12-19 2025-12-18 S Sale
1.8
Van Tuyl Christopher

Chief Legal Officer

Officer
2,284 -1.5%
27.38
US$62,536 		2,284 -1.5% 27.38 US$62,536
2025-12-19 2025-12-18 S Sale
1.8
Van Tuyl Christopher

Chief Legal Officer

Officer
8,529 -5.3%
26.78
US$228,407 		8,529 -5.3% 26.78 US$228,407
2025-12-12 2025-12-12 B Purchase
1.9
Roivant Sciences Ltd.
Non-Executive Director Large shareholder
16,666,666 +17.2%
21.00
US$349,999,986 		16,666,666 +17.2% 21.00 US$349,999,986
2025-12-03 2025-12-01 PlS Planned sale
Fromkin Andrew J.
Non-Executive Director
2,898 -3.3%
23.95
US$69,407 		2,898 -3.3% 23.95 US$69,407
2025-12-03 2025-12-01 PlS Planned sale
Fromkin Andrew J.
Non-Executive Director
19,351 -17.9%
23.14
US$447,782 		19,351 -17.9% 23.14 US$447,782
2025-12-03 2025-12-01 PlS Planned sale
Hughes Douglas J.
Non-Executive Director
1,909 -1.6%
23.96
US$45,740 		1,909 -1.6% 23.96 US$45,740
2025-12-03 2025-12-01 PlS Planned sale
Hughes Douglas J.
Non-Executive Director
13,091 -9.6%
23.14
US$302,926 		13,091 -9.6% 23.14 US$302,926
2025-12-01 2025-12-01 PrS Proposed sale
ANDREW J FROMKIN

Director

Non-Executive Director
22,249
24.15
US$537,313 		22,249 24.15 US$537,313
2025-12-01 2025-12-01 PrS Proposed sale
DOUGLAS HUGHES

Director

Non-Executive Director
15,000
24.15
US$362,250 		15,000 24.15 US$362,250
2025-11-26 2025-11-26 PrS Proposed sale
3.3
MICHAEL GEFFNER

Officer

Officer
50,000
23.70
US$1,185,045 		50,000 23.70 US$1,185,045
2025-11-25 2025-11-25 PrS Proposed sale
3.3
MICHAEL GEFFNER

Officer

Officer
103,897
23.38
US$2,428,804 		103,897 23.38 US$2,428,804
2025-11-21 2025-11-20 S Sale
1.8
Gloria Melanie

Chief Operating Officer

Officer
2,375 -1.4%
23.97
US$56,929 		2,375 -1.4% 23.97 US$56,929
2025-11-21 2025-11-20 S Sale
1.8
Gloria Melanie

Chief Operating Officer

Officer
10,251 -5.5%
23.54
US$241,309 		10,251 -5.5% 23.54 US$241,309
2025-10-24 2025-10-22 S Sale
3.3
Geffner Michael

Chief Medical Officer

Officer
2,595 -1.2%
19.03
US$49,383 		2,595 -1.2% 19.03 US$49,383
2025-10-24 2025-10-22 S Sale
2.4
Stout Jay S

Chief Technology Officer

Officer
2,520 -1.2%
19.03
US$47,956 		2,520 -1.2% 19.03 US$47,956
2025-10-10 2025-10-08 S Sale
2.4
Stout Jay S

Chief Technology Officer

Officer
1,585 -0.8%
16.30
US$25,836 		1,585 -0.8% 16.30 US$25,836
2025-10-10 2025-10-08 S Sale
3.3
Geffner Michael

Chief Medical Officer

Officer
1,272 -0.6%
16.30
US$20,734 		1,272 -0.6% 16.30 US$20,734
2025-07-25 2025-07-23 S Sale
2.4
Stout Jay S

Chief Technology Officer

Officer
2,805 -1.4%
18.15
US$50,911 		2,805 -1.4% 18.15 US$50,911
2025-07-25 2025-07-23 S Sale
3.3
Geffner Michael

Chief Medical Officer

Officer
2,385 -1.1%
18.15
US$43,288 		2,385 -1.1% 18.15 US$43,288
2025-07-11 2025-07-09 S Sale
2.4
Stout Jay S

Chief Technology Officer

Officer
1,519 -0.7%
17.24
US$26,188 		1,519 -0.7% 17.24 US$26,188
Explore more

More insider trading research around Immunovant Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America